Cellular and molecular mechanisms in chronic myeloid leukaemia: Biology and treatment

British Journal of Haematology

Volumn 95, Issue 1, 1996, Pages 10-20

  Gordon, M Y ^a   Goldman, J M ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON;

CHRONIC MYELOID LEUKEMIA; HUMAN; ONCOGENE; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; REVIEW;

HUMANS; LEUKEMIA, MYELOID, CHRONIC; TRANSLOCATION, GENETIC;

EID: 0029798501     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (118)

1. Afar, D.E., Goga, A., McLaughlin, J., Witte, O.N. & Sawyers, C.L. (1994) Differential complementation of Ber-Abl point mutations with c-Myc. Science, 264, 424-426.
2. Ahuja, II., Bar-Eli. M., Advani, S.H., Benchimol, S. & Cline, M.J. (1989) Alterations in the p53 gene and the clonal evolution of the blast crisis of chronic myelocytic leukemia. Proceedings of the National Academy of Science of the United Sates of America, 86, 6783-6787.
3. Ahuja, H., Bar-Eli, M., Arlin, X., Advani, S., Allen, S.L., Goldman, J., Snyder, D., Foti, A. & Cline, M. (1991) The spectrum of molecular alterations in the evolution of chronic myelocytic leukemia. Journal of Clinical Investigation. 87, 2042-2047.
4. Ames, B.N. & Bold, L.S. (1990) Too many rodent carcinogens: mitogenesis increases mutagenesis. Science, 249, 970-971.
5. Amos, T.A.S., Lewis, J.L., Grand, F.H., Gooding, R.P., Goldman. J.M. & Gordon, M.Y. (1995) Apoptosis in chronic myeloid leukaemia: normal responses by progenitor cells to growth factor deprivation, X-irradiation and glucocorticoids. British Journal of Haematology, 91, 387-393.
6. Antin, J.H. (1993) Graft-versus-leukemia: no longer an epiphenomenon. Blood, 82, 2273-2277.
7. Banavall, S.D. & Advani. S.H. (1991) A hypothetical model to explain the termination of chronic myeloid leukemia into blast crisis. Medical Hypotheses. 34, 111-115.
8. Bartram, C.R., Jannsen, J.W.G., Becher, R., de Klein, A. & Grosfeld, G. (1986) Persistence of chronic myelocytic leukemia despite deletion of rearranged BCR-ABL sequences in blast crisis. Journal of Experimental Medicine, 164, 1389-1396.
9. Bedi, A., Barber, J.P., Bedi, G.C., el Deiry, W.S., Sidransky, D., Vala, M.S., Akhtar, A.J., Hilton, J. & Jones, R.J. (1995) BCR-ABL-mediated inhibition of apoptosis with delay of G2/M transition after DNA damage: a mechanism of resistance to multiple cancer agents. Blood, 86, 1148-1158.
10. Bedi, A., Zenbauer, B.A., Barber, J.P., Sharkis, S.J. & Jones, R.J. (1994) Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia. Blood. 83, 2038-2044.
11. Ben-Neriah, Y., Daley, G.Q., Mes-Masson, A.-M., Witte, O.N. & Baltimore, D. (1986) The chronic myelogenous leukemia-specific p210 protein is the product of the brc-abl hybrid gene. Science. 233, 212-214.
12. Bernstein, I.D., Singer, J.W., Smith, F.O., Andres, R.G., Flowers, D.A., Petersens, J., Steinmann, L., Najfeld, V., Savage, D., Fruchtman, S., Arlin, Z. & Fialkow, P.J. (1992) Differences in the frequency of normal and clonal precursors of colony-forming cells in chronic myelogenous leukemia and acute myelogenous leukemia. Blood. 79, 1811-1816.
13. Bhatia, R., Wayner, E.A., McGlave, P.B. & Verfaillie, C.M. (1994) Interferon-alpha restores normal adhesion of chronic myelogenous leukemia hematopoietic progenitors to bone marrow stroma by correcting impaired beta 1 integrin receptor function. Journal of Clinical Investigation, 94, 384-391.
14. Biernaux, C., Loos, M., Sels, A., Huez. G. & Stryckmans, P. (1995) Detection of major bcr-abl gene expression at a very low level in blood cells of some healthy individuals. Blood, 86, 3118-3122.
15. Bocchia, M., Wentworth, P.A., Southwood, S., Sidney, J., McGraw, K., Scheinberg, D.A. & Sette, A. (1995) Specific binding of leukemia oncogene fusion protein peptides to HLA class I molecules. Blood, 85, 2680-2684.
16. Borok, R. & Preisler, H. (1994) A mathematical model of chronic myelogenous leukemia (CML) chronic phase. (Abstract). Blood, 84, (Suppl. 1), 629.
17. Brito-Babapulle, F., Bowcock, S.J., Marcus, R.E., Apperley. J., Th'ng. K.H., Dowding, C., Rasool, F., Guo, A.-P., Catovsky, D., Galton, D.A.G., McCarthy, D. & Goldman, J.M. (1989) Autografting for patients with chronic myeloid leukaemia in chronic phase: peripheral blood stem cells may have a finite capacity for maintaining haemopoiesis. British Journal of Haematology, 73, 76-81.
18. Carella, A.M., Podesta, M., Frassoni, F., Raffo, M.R., Pollicardo, N., Pungolino, E., Vimercati, R., Sessarego, M., Parodi, C., Rabitti, C., Ferrero, R., Benvenuto, F., Figari, O., Carlier, P., Levcasic, G., Valbonesi, M., Vitale, V., Giordano, D., Pierluigi, D., Nati, S., Guerracio, A., Rosso, C. & Saglio, G. (1993) Collection of 'normal' blood repopulating cells during early hemopoietic recovery after intensive conventional chemotherapy in chronic myelogenous leukemia. Bone Marrow Transplantation, 12, 267-271.
19. Chervenick, P.A., Ellis, L.D., Pan, S.F. & Lawson, A.L. (1971) Human leukemic cells: in vitro growth of colonies containing the Philadelphia chromosome. Science, 174, 1134-1136.
20. Cline, M.J., Jat, P.S. & Foti, A. (1992) Molecular mechanisms in the evolution of chronic myelocytic leukemia. Leukemia and Lymphoma, 7, 283-287.
21. Cohen, S.M. & Ellwein, L.B. (1990) Cell proliferation in carcinogenesis. Science. 249, 1007-1011.
22. Collins, S.J. (1986) Breakpoints on chromosomes 9 and 22 in Philadelphia chromosome positive chronic myelogenous leukemia. Journal of Clinical Investigation, 78, 1392-1396.
23. Collins, S.J., Kubonishi, I., Myoshi, I. & Groudine. M. (1984) Altered transcription of the abl oncogene in K562 and other chronic myelogenous leukemia cells. Science. 225, 72-74.
24. Conolly, R.B. & Kimbell, J.S. (1994) Computer simulation of cell growth governed by stochastic processes: application to clonal growth cancer models. Toxicology and Applied Pharmacology. 124, 284-295.
25. Daley, G.Q. & Baltimore, D. (1988) Transformation of an interleukin-3 dependent hematopoietic cell line by the chronic myelogenous leukemia-specific bcr-abl protein. Proceedings of the National Academy of Sciences of the United States of America, 85, 9312-9315.
26. Diamond, J., Goldman, J.M. & Melo, J.V. (1995) BCR-ABL. ABL-BCR, BCR and ABL genes are all expressed in individual granulocytemacrophage colony-forming unit colonies derived from blood of patients with chronic myeloid leukemia. Blood. 85, 2171-2175.
27. Dowding , C., Gordon, M., Guo, A.-P., Maisin, D., Osterholz. J., Siczkowskl. M. & Goldman, J. (1993) Potential mechanisms of action of interferon-α in CML. Leukemia and Lymphoma. 11, (Suppl. 1), 185-191.
28. Dowding, C., Guo, A.-P., Maisin, C., Gordon, M. & Goldman, J. (1991a) The effects of interferon-α on the proliferation of CML progenitor cells are not related to the precise position of the MBCR breakpoint. British Journal of Haematology, 77, 165-171.
29. Dowding, C., Guo, A.-P., Osterholz, J., Sicskowski, M., Goldman. J. & Gordon, M. (1991b) Interferon-α overrides the deficient adhesion of chronic myeloid leukemia primitive progenitor cells to bone marrow stromal cells. Blood, 78, 499-505.
30. Dowding, C.R., Gordon, M.Y. & Goldman, J.M. (1986) Primitive progenitor cells In the blood of patients with chronic granulocytic leukemia. International Journal of Cell Cloning. 4, 331-340.
31. 6-alkylguanine-DNA alkyltransferase. Science. 259, 219-222.
32. Dumbar, C.E. & Stewart, F.M. (1992) Separating the wheat from the chaff: selection of benign hematopoietic cells in chronic myeloid leukemia. Blood, 79, 1107-1110.
33. Eaves, C.J. & Eaves. A.C. (1987) Cell culture studies in CML. Bailliere's Clinical Haematology, 1, 931-961.
34. Eaves, C., Udomsakdl, C., Cashman, J., Barnett. M. & Eaves, A. (1993) The biology of normal and neoplastic stem cells in CML. Leukemia and Lymphoma, 11, (Suppl. 1), 245-253.
35. Eisbruch, A., Blick, M., Evinger-Hodges, M.J., Beran, M., Andersson, B., Gutterman, J.U. & Kurzrock. R. (1988) Effect of differentiating inducing agents on oncogene expression in a chronic myelogenous leukemia cell line. Cancer, 62, 1171-1178.
36. Flalkow, P.J., Martin, P.J., Najfeld, V., Penfold, G.F., Jacobson, R.J. & Hansen, J.A. (1981) Evidence for a multistep pathogenesis of chronic myelogenous leukemia. Blood. 58, 158-163.
37. Floretos, T., Heisterkamp, N. & Groffen, J. (1994) No evidence for imprinting of the human BCR gene. Blood. 83, 3441-3444.
38. Ford, R. & Maizel, A. (1986) Mediators in Cell Growth and Differentiation. Raven Press, New York.
39. Foti, A. & Cline, M.J. (1994) Sequential relapses of blastic crisis may Involve different clones of cells with different molecular abnormalities. British Journal of Haematology. 87, 627-630.
40. Gale, R.P. (1987) Chronic myelogenous leukemia: a model for human cancers. Bailliere's Clinical Haematology, 1, 869-886.
41. Galvani, D. & Crawley, C. (1989) Mechanism of action of α-interferon in chronic granulocytic leukaemia: evidence for preferential inhibition of late progenitors. British Journal of Haematology, 73, 475-479.
42. Giralt, S., Kantarjian, H. & Talpaz, M. (1995) The natural history of chronic myelogenous leukemia in the interferon era. Seminars in Hematology, 32, 152-158.
43. Glsslinger, H., Kurzrock, R., Wetzler, M., Robertson, L., Kantarjlan, H. & Talpaz, M. (1994) Comparison of apoptosis and survival in CML and normal neutrophils. (Abstract). Blood, 84, (Suppl. 1), 156.
44. Goga, A., McLaughkin, J., Afar, D.E., Saffran, D.C. & Witte, O.N. (1995) Alternative signals to RAS for hematopoietic transformation by the BCR-ABL oncogene. Cell, 82, 981-988.
45. Goldman, J.M. (1990) Options for the management of chronic myeloid leukemia, 1990. Leukemia and Lymphoma, 3, 159-164.
46. Goldman, J.M., Gale, R.P., Horowitz, M.M., Biggs, J.C., Champlin, R.E., Gluckman, E., Jabobsen, S.J., Marmont, A.M., McGlave, P.B., Messner, H.A., Rimm, A.A., Rozman, C., Speck, B., Tura, S., Weiner, R.S. & Bortin, M.M. (1988) Bone marrow transplantation for chronic myelogenous leukemia: increased risk for relapse associated with T cell depletion. Annals of Internal Medicine, 108, 806-814.
47. Goldman, M.J. & O'Brien, S.G. (1993) Residual Ph-negative stem cells In chronic myeloid leukemia: sometimes or always? Stem Cells, 11, (Suppl. 3), 4-7.
48. Goldman, J.M., Shiota, F., Th'ng, K.H. & Orchard, K.H. (1980) Circulating granulocytic and erythroid progenitor cells in chronic granulocytic leukaemia. British Journal of Haematology, 46, 7-13,
49. Gordon, M.Y. (1993) Cell biology of CML: a model linking the chronic and terminal phases, Leukemia and Lymphoma, 11, (Suppl. 1), 93-100.
50. Gordon, M.Y. & Blackett, N.M. (1994) Routes to repopulation: a unification of the stochastic model and separation of stem cell subpopulations. Leukemia, 8, 1068-1073.
51. Gordon, M.Y., Dowding, C.R., Rlley, G.P., Goldman, J.M. & Greaves, M.F. (1987) Altered adhesive Interactions with marrow stroma of haematopoietic progenitor cells in chronic myeloid leukaemia. Nature, 328, 342-344.
52. Gordon, M.Y., Lewis, J.L. & Goldman, J.M. (1995a) Influence of cultured bone marrow-derived stromal cells on the proliferative activity of primitive hematopoietic progenitor cells. (Abstract). Experimental Hematology, 23, 784.
53. Gordon, M.Y., Lewis, J.L. & Goldman, J.M. (1995b) Stromal cells stimulate rather than restrain primitive progenitor cell activity in chronic myeloid leukemia (CML). (Abstract). Blood, 86, (Suppl. 1), 523.
54. Griffin, J.D., Okuda, K., Sattler, M., Uemara, N. & Salgia, R. (1995) Mechanisms of transformation in primary CML cells. (Abstract). Experimental Hematology, 23, 895.
55. Groffen, J., Stephenson, J.R., Heisterkamp, N., de Klein, A., Bartram, C.R. & Grosveld, G. (1984) Philadelphia chromosomal break-points are clustered within a limited region, ber, on chromosome 22. Cell, 36, 93-99.
56. Guinn, B.A., Smith, M., Padua, R.A., Burnett, A. & Mills, K. (1995) Changing p53 mutations with the evolution of chronic myeloid leukaemia from the chronic phase to blast crisis. Leukaemia Research, 19, 519-525.
57. Haas, D.A., Argyriou-Tirita, A. & Lion, T. (1992) Parental origin of chromosomes involved in the translocation t(9:22). Nature, 359, 414-416.
58. Hariharan, I.K., Adams, J.M. & Cory, S. (1988) ber-abl oncogene renders myeloid cell line factor independent: potential autocrine mechanisms in chronic myeloid leukemia. Oncogene Research. 3, 387-399.
59. Howard, O., Talpaz, M., Kantarjian, H., Seong, D., Wedrychowski, A., Paslidis, N., Hester, J., Cork, A., Turpin, J., Lopez-Bernstein, G., Trujillo, J., Gutterman, J., Friereich, E. & Deisseroth, A. (1990) Interferon affects nuclear proteins in cells of clinically sensitive chronic myelogenous leukemia patients, Blood, 76, 1117-1130.
60. Jehn, U., Mittermuller, J., Greither, L., Clemen, C.H., Heinemann, V., Lorenz, T. & Gross, H. (1989) Repeated blast crisis of changing morphology, immunologic phenotype and cytogenetics in chronic myelogenous leukemia. Anticancer Research, 9, 1721-1723.
61. Jiang, Y.Z., Kanfer, E.J., Macdonald, D., Cullis, J.O., Goldman, J.M. & Barrett, A.J. (1991a) Graft-versus-leukaemia following allogeneic bone marrow transplantation: emergence of cytotoxic T lymphocytes reacting to host leukaemia cells. Bone Marrow Transplantation, 8, 253-258.
62. Jiang, Y.Z., Macdonald, D., Cullis, J.O. & Barrett, A.J. (1991b) Is graft versus leukaemia separable from graft versus host disease. Bone Marrow Transplantation, 7. (Suppl. 2), 26.
63. Jibrin, I.M. (1995) Possible significance of Ph. zine and BCR-ABL chimaerism in the pathogenesis of chronic myeloid leukaemia. Medical Hypotheses, 44, 301-305.
64. Keating, A., Wang, X.-H. & Laraya, P. (1994) Variable transcription of BCR-ABL by Ph' cells arising from hematopoietic progenitors in chronic myeloid leukemia. Blood, 83, 1744-1749.
65. Kiyoi, H., Fukutani, H., Yamauchi, T., Kubo, K., Ohno, R., Yamamori, S. & Naoe, T. (1995) Continuing immunoglobulin heavy chain rearrangements in chronic myeloid leukemia with recurrent B-lymphoid blast crisis after bone marro transplantation. Leukemia, 9, 265-270.
66. Kloetzer, W., Kurzrock, R., Smith, L., Talpaz, M., Spiller, M., Gutterman, J. & Arlinghaus, R. (1985) The human cellular ABL gene product in the chronic myelogenous leukemia cell line K562 has an associated tyrosine protein kinase activity. Virology, 140, 230-238.
67. Kolb, H.J., Mittermuller, J., Clemm, Ch., Holler, E., Ledderose, G., Brehm, G., Heim, M. & Wilmanns, W. (1990) Donor leukocyte transfusions for treatment of recurrent myelogenous leukemia in marrow transplant patients. Blood, 76, 2462-2465.
68. Konopka, J.B., Clarke, S., McLaughlin, J., Nita, M., Kato, Y., Strife, A., Clarkson, B. & Witte, O.N. (1986) Variable expression of the translocated ABL oncogene in Philadelphia chromosome-positive B-lymphoid cell lines from chronic myelogenous leukemia patients. Proceedings of the National Academy of Science of the United States of America, 83, 4049-4152.
69. 1-positive chronic myelogenous leukemia patients express ABL proteins with a common structural alteration. Proceedings of the National Academy of Sciences of the United States of America, 82, 1810-1814.
70. Konopka, J.B., Watanabe, S.M. & Witte, O.N. (1984) An alteration of the human ABL protein in K562 leukemia cells unmasks associated tyrosine kinase activity. Cell, 37, 1035-1043.
71. Laneuville, P. & Sullivan, A.K. (1991) Clonal succession and deletion of bcr-abl sequences in chronic myeologenous leukemia with recurent lymphoid blast crisis. Leukemia, 5, 752-756.
72. Laneuville, P., Sun, G., Tlmm, M. & Vekemans, M. (1992) Clonal evolution in a myeloid cell line transformed to interleukin-3 independent growth by retroviral transduction and expression of p210 bcr/abl. Blood, 80, 1788-1797.
73. Limpens, J., Stad, R., Vos, C., de Vlaam, C., de Jong, D., van Ommen, G.-J. B., Schuuring, E. & Kliun, P.M. (1996) Lymphoma-associated translocation t(14;18) in blood B cells of normal individuals. Blood (in press).
74. Liu, Y., Hernandez, A.M., Shibata, D. & Cortopassi, G. (1994) Bcl 2 translocation frequency rises with age in humans. Proceedings of the National Academy of Sciences of the United Sates of America, 91, 8910-8914.
75. Liu, E., Hjelle. B. & Bishop, J.M. (1998) Transforming genes in chronic myelogenous leukemia. Proceedings of the National Academy of Sciences of the United States of America, 85, 152-156.
76. Marley, S.B., Lewis, J.L., Goldman, J.M. & Gordon, M.Y. (1996) Abnormal kinetics of colony formation by crythroid burst-forming units in chronic myeloid leukaemia. British Journal of Haematology, 93, 878-883.
77. Matsuguchi, T., Salgia, R., Hallek, M., Eder, M., Druker, B., Ernst, T.J. & Griffin, J.D. (1994) She phophorylation in myeloid cells is regulated by granulocyte macrophage colony-stimulating factor and is constitutively increased by p210BCR/ABL. Journal of Biological Chemistry, 269, 5016-5021.
78. BCR-ABL tyrosine protein kinase activity in various subtypes of Philadelphia chromosome positive cells from chronic myelogenous leukemia patients. Cancer Research, 47, 1731-1739.
79. McGahon, A., Bissonnette, R., Schmitt, M., Cotter, K.M., Green, D.R. & Cotter, T.G. (1994) Bcr-abl maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death. Blood, 83, 1179-1184.
80. McWhirter, J. & Wang, J. (1993) An actin-binding function contributes to transformation by the Bcr-Abl oncoprotein of Philadelphia chromosome-positive human leukemias. EMBO Journal, 12, 1533-1546.
81. Melo, J.V., Hochhaus, A., Yan, X.-H. & Goldman, J.M. (1996) Lack of correlation between ABL-BCR expression and response to interferon-α in chronic myeloid leukaemia. British Journal of Haematology, 92, 684-686.
82. Melo, J.V., Yan, X.-H., Diamond, J. & Goldman, J.M. (1994) Lack of imprinting of the ABL gene. Nature Genetics, 8, 318-319.
83. Melo, J.V., Yan, X.-H., Diamond, J. & Goldman, J.M. (1995) Balanced parental contribution of the ABL component of the BCR-ABL gene in chronic myeloid leukemia. Leukemia, 9, 734-739.
84. Mitelman, F. (1993) The crytogenetic scenario of chronic myeloid leukemia. Leukemia and Lymphoma, 11, 11-15.
85. Nowell, P.C. (1986) Mechanisms of tumour progression. Cancer Research, 46, 2203-2207.
86. Nowell, P.C. & Hungerford, D.A. (1960) A minute chromosome in human chronic granulocytic leukemia. Science, 132, 1497-1501.
87. Oda, T., Heaney, C., Hagopian, J.R., Okuda, K., Griffin, J.D. & Druker, B.J. (1994) Crkl is the major tyrosine phosphorylated protein in neutrophils from patients with chronic myelogenous leukemia. Journal of Biological Chemistry, 269, 229255-229258.
88. Odai, T., Sasaki, T., Iwamatsu, A., Hanazono, V., Takaka, T., Mitani, K., Vazaki, V. & Hirai, H. (1995) The proto-oncogene product c-Cbl becomes tyrosine phosphorylated by stimulation of G-CSF or Epo and constitutively binds to the SH3 domain of Grb2/ Ash in human hematopoietic cells. Journal of Biological Chemistry, 270, 10800-10805.
89. Puil, L., Gish, G., Mbamalu, G., Bowtell, D., Pelicci, P.G., Arlinghaus, R. & Pawson, T. (1994) Bcr-Abl oncoproteins bind directly to activators of the Ras signalling pathway. EMBO Journal, 13, 764-773.
90. Raskind, W.H., Ferraris, A.M., Najfeld, V., Jacobson, R.H., Moohr, J.W. & Fialkow, P.J. (1993) Further evidence for the existence of a clonal Ph-negative stage in some cases of Ph-positive chronic myelocytic leukemia. leukemia, 7, 1163-1167.
91. Riggins, G.J., Zhang, F. & Warren, S.T. (1994) Lack of imprinting of BCR. (Letter). Nature Genetics, 6, 226.
92. Roger, R., Isaad, C., Pallardy, M., Leglise, M.-C., Turhan, A.G., Bertoglio, J. & Breard, J. (1996) BCR-ABL does not prevent apoptotic death induced by human natural killer or lymphokine activated killer cells. Blood, 87, 1113-1122.
93. Romero, P., Blick, M., Talpaz, M., Murphy, E., Hester, J. & Gutterman, J. (1986) C-sis and c-abl expression in chronic myelogenous leukemia and other hematological malignancies. Blood, 67, 839-841.
94. Rosales, C., O'Brien, V., Kornberg, L. & Juliano, R. (1995) Signal transdnction by cell adhesion receptors. Biochimica et Biophysica Acta, 1242, 77-98.
95. Rowley, J.D. (1973) A new consistent chromosome abnormality in chronic myelogenous leukaemia detected by quinacrine fluorescence and Giemsa staining. Nature, 243, 290-293.
96. Rubin, H. (1993) Cellular epigenetics: effects of passage history on competence of cells for 'spontaneous' transformation. Proceedings of the National Academy of Sciences of the United States of America, 90, 10715-10719.
97. Salgia, R., Brunkhorst, B., Pisick, E., Li, J.L., Lo, S.H., Chen, L.B. & Griffin, J.D. (1995) Increased tyrosine phosphorylation of focal adhesion proteins in myeloid cell lines expressing p210BC/ABL. Oncogene, 11, 1149-1155.
98. Salgia, R., Sattler, M., Pisick, E., Li, J.-L. & Griffin, J.D. (1996) p210BCR-ABL induces formation of complexes containing focal adhesion proteins and the protooncogene product p120c-CBL, Experimental Hematology, 24, 310-313.
99. Santucci, M.A., Anklesaria, P., Laneuville, P., Das, I.J., Fitzgerald, T.J. & Greenherger, J.S. (1993) Expression of p210 BCR/ABL increases hematopoietic progenitor cell radiosensitivity. International Journal of Radiation Oncology, Biology and Physics, 26, 881-889.
100. Sattler, M., Salgia, R., Okuda, T., Uemara, N., Dustin, M., Pisick, E., Xu, G., Li, J.-L., Prasad, K.V. & Griffin, J.D. (1996) The protooncogene product p120CBL and the adaptor proteins CRKL and c-CRK link c-ABL. p190BCR/ABL and p210BCR/ABL to the phosphatidylinositol-3′ kinase pathway. Oncogene, 12, 839-845.
101. Sayers, C.L. (1993) The role of myc in transformation by BCR-ABL. Leukemia and Lymphoma, 11, (Suppl. 1) , 45-46.
102. Sawyers, C.L., Callahan, W. & Witte, O.N. (1992) Dominant negative MYC blocks tranformation by ABL oncogenes. Cell, 70, 901-910.
103. Sawyers, C.L., McLaughlin, J., Goga, A., Havlik, M. & Witte, O. (1994) The nuclear tyrosine kinase c-ABL negatively regulates cell growth. Cell, 77, 121-131.
104. Sawyers, C.L., McLauglin, J. & Witte, O.N. (1995) Genetic requirement for Ras in the transformation of fibroblasts and hematopoietic cells by the Bcr-Abl oncogene. Journal of Experimental Medicine, 181, 307-313.
105. Shtalrid, M., Talpaz, M., Kurzrock, R., Kantarjian, H., Trujillo, J., Gutterman, J., Yoffe, G. & Blick, M. (1988) Analysis of breakpoints within the BCR gene and their correlation with the clinical course of chronic myelogenous leukemia. Blood, 72, 485-490.
106. Shtivelman, E., Gale, R., Dreazen, O., Berrehi, A., Zaizov, R., Kubonishi, I., Miyoshi, I. & Canaani, E. (1987) BCR-ABL RNA in patients with chronic myelogenous leukemia. Blood, 69, 971-973.
107. Sill, H., Chase, A., Mills, K.A., Apfelbeck, U., Sormann, S., Goldman, J.M. & Cross, N.C. (1994) No evidence for microsatelite instability or consistent loss of heterozygosity at selected loci in chronic myeloid leukemia blast crisis. Leukemia, 8, 1923-1928.
108. Sill, H., Goldman, J.M. & Cross, N.C. (1995) Homozygous deletions of the p16 tumor-suppressor gene are associated with lymphoid transformation of chronic myeloid leukemia. Blood, 85, 2013-2016.
109. Spencer, A., Vulliamy, T., Goldman, J.M. & Melo, J.V. (1996a)) Myeloid to lymphoid clonal succession following autologous transplantation in second chronic phase, Leukemia, in press.
110. Spiers, A.S.D. (1977) The clinical features of chronic granulocytic leukaemia. Clinics in Haematology, 6, 77-95.
111. Tauchi, T., Boswell, H.S., Lebowitz, D. & Broxmeyer, H.E. (1994) Coupling between p210bcr-abl and She and Grb2 adaptor proteins in hematopoietic cells permits growth factor receptor-independent link to ras activation pathway. Journal of Experimental Medicine, 713, 167-175.
112. Tisty, T.D., White, A. & Sanchez, J. (1996) Suppression of gene amplification in human cell hybrids. Science, 255, 1425-1427.
113. Udomsakdi, C., Eaves, C.J., Swolin, B., Reid, D.S., Barnett, M.J. & Eaves, A.C. (1992) Rapid decline in chronic myeloid leukemia cells in long-term culture due to a defect at the stem cell level. Proceedings of the National Academy of Sciences of the United States of America, 89, 6192-6196.
114. Upadhyaya, G., Guba, S., Sih, S., Feinberg, A., Talpaz, M., Kantarjian, H., Deisseroth, A. & Emerson, S. (1991) Interferon-alpha restores the deficient expression of the cyto-adhesion molecule lymphocyte function antigen-3 by chronic myelogenous leukemia progenitor colls. Journal of Clinical Investigation, 88, 2131-2136.
115. Verfaillie C.M. (1992) Direct contact between human primitive hematopoietic progenitors and bone marrow stroma is not required for long-term in vitro hematopoiesis. Blood, 79, 2821-2826.
116. Wada, C., Shionoya, S., Fujino, Y., Tokuhiro, H., Akahoshi, T., Uchida, T. & Ohtani, H. (1994) Genomic instability of microsatellite repeats and its association with the evolution of chronic myelogenous leukemia, Blood, 83, 3449-3456.
117. Wang, C., Auger, K.R., Jarvis, L., Shi, Y. & Roberts, T.M. (1995) Direct association of Grb2 with the p85 subunit of phosphatidylinositol-3′ kinase. Journal of Biological Chemistry, 270, 12774-12780.
118. Wright, J.A., Smith, H.S., Wyatt, F.M., Hancock, M.C., Hudson, D.C. & Stark, G.R. (1990) DNA amplification is rare in normal human cells. Proceedings of the National Academy of Sciences of the United States of America, 87, 1791-1795.